• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过用黑色素瘤抗原A27L肽类似物进行体外刺激来分析黑色素瘤中细胞毒性T淋巴细胞反应:一项定性分析

Cytotoxic T-lymphocyte responses in melanoma through in vitro stimulation with the Melan-A peptide analogue A27L: a qualitative analysis.

作者信息

Palermo B, Campanelli R, Garbelli S, Mantovani S, Robustelli Della Cuna G, Necker A, Manganoni A M, Carella G, Rivoltini L, Lantelme E, Giachino C

机构信息

Experimental Immunology, IRCCS Maugeri Foundation, Pavia, Italy.

出版信息

Melanoma Res. 2002 Oct;12(5):491-8. doi: 10.1097/00008390-200209000-00011.

DOI:10.1097/00008390-200209000-00011
PMID:12394191
Abstract

Modifications in tumour antigen-derived epitopes that stabilize the major histocompatibility complex (MHC)-peptide complex result in enhanced stimulatory capacity and improved immunogenicity of the altered peptide. These epitope analogues are attractive candidates for the development of peptide-based vaccine trials. Any modification, however, in tumour antigens may induce T-cell responses that could either fail to react against the naturally occurring peptides or represent only a subset of the total antigen-specific repertoire. In the present study, we performed a critical analysis of the ability of cytotoxic T-lymphocyte (CTL) clones, derived from two melanoma patients through stimulation with the A27L peptide analogue, to cross-react with the naturally processed Melan-A/MART-1 (Melan-A) peptides in terms of T-cell receptor (TCR) affinity, functional avidity and fine antigen specificity. We found that all the A27L-specific clones analysed possessed a very low avidity for the natural Melan-A peptides, and that their binding affinity for human leukocyte antigen (HLA) tetramers complexed with both the modified and the natural Melan-A peptides did not strictly correlate with their functional avidity. We also observed that these clones were able to cross-recognize both natural Melan-A peptides in one patient, but only one peptide in the second patient. We discuss the capability of the A27L peptide analogue to stimulate all the available Melan-A-specific repertoire.

摘要

对肿瘤抗原衍生表位进行修饰,使主要组织相容性复合体(MHC)-肽复合物稳定,可增强修饰肽的刺激能力并改善其免疫原性。这些表位类似物是基于肽的疫苗试验开发的有吸引力的候选物。然而,肿瘤抗原的任何修饰都可能诱导T细胞反应,这种反应可能无法对天然存在的肽产生反应,或者仅代表总抗原特异性库的一个子集。在本研究中,我们对通过用A27L肽类似物刺激从两名黑色素瘤患者获得的细胞毒性T淋巴细胞(CTL)克隆与天然加工的黑色素瘤抗原A/MART-1(Melan-A)肽发生交叉反应的能力进行了批判性分析,分析内容涉及T细胞受体(TCR)亲和力、功能亲和力和精细抗原特异性。我们发现,所有分析的A27L特异性克隆对天然Melan-A肽的亲和力都非常低,并且它们与修饰和天然Melan-A肽复合的人白细胞抗原(HLA)四聚体的结合亲和力与其功能亲和力并不严格相关。我们还观察到,这些克隆能够交叉识别一名患者中的两种天然Melan-A肽,但在另一名患者中只能识别一种肽。我们讨论了A27L肽类似物刺激所有可用的Melan-A特异性库的能力。

相似文献

1
Cytotoxic T-lymphocyte responses in melanoma through in vitro stimulation with the Melan-A peptide analogue A27L: a qualitative analysis.通过用黑色素瘤抗原A27L肽类似物进行体外刺激来分析黑色素瘤中细胞毒性T淋巴细胞反应:一项定性分析
Melanoma Res. 2002 Oct;12(5):491-8. doi: 10.1097/00008390-200209000-00011.
2
Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.黑色素瘤患者中黑色素瘤抗原A/黑色素瘤相关抗原-1特异性CD4 T细胞:新表位的鉴定及通过II类主要组织相容性复合体四聚体对特异性T细胞进行体外可视化分析
J Immunol. 2006 Nov 15;177(10):6769-79. doi: 10.4049/jimmunol.177.10.6769.
3
Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clones.通过针对预先选择的高度免疫原性黑色素瘤细胞克隆进行体外免疫,建立gp100和MART-1/黑色素A特异性细胞毒性T淋巴细胞克隆。
Cancer Immunol Immunother. 1999 Aug;48(5):239-46. doi: 10.1007/s002620050571.
4
Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.体内肽特异性CD8 + T细胞的演变:对Melan-A/MART-1肽疫苗接种的反应。
Int J Cancer. 2002 Mar 20;98(3):376-88. doi: 10.1002/ijc.10165.
5
Induction of anti-melanoma CTL response using DC transfected with mutated mRNA encoding full-length Melan-A/MART-1 antigen with an A27L amino acid substitution.
Cell Immunol. 2003 Aug;224(2):86-97. doi: 10.1016/j.cellimm.2003.08.005.
6
HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.在长肽中对黑素瘤-A 抗原-HLA-A2 表位进行 HLA 锚点优化,是提高人肿瘤反应性 T 细胞交叉呈递效率所必需的。
J Immunol. 2012 Mar 1;188(5):2102-10. doi: 10.4049/jimmunol.1101807. Epub 2012 Jan 30.
7
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide.针对免疫显性的黑色素瘤抗原A/MART-1抗原肽的HLA-A*0201限制性细胞毒性T淋巴细胞所表现出的精细特异性的多样性。
J Immunol. 1998 Dec 15;161(12):6956-62.
8
Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A.细胞毒性T淋巴细胞可识别源自黑色素瘤相关抗原MART-1/Melan-A的多种肽异构体。
Int J Cancer. 1999 Jun 11;81(6):979-84. doi: 10.1002/(sici)1097-0215(19990611)81:6<979::aid-ijc22>3.0.co;2-y.
9
Overlapping peptides of melanocyte differentiation antigen Melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1.与HLA - B45.1和HLA - A2.1相关的、被自体细胞溶解性T淋巴细胞识别的黑素细胞分化抗原Melan - A/MART - 1的重叠肽段。
Int J Cancer. 1998 Jan 30;75(3):451-8. doi: 10.1002/(sici)1097-0215(19980130)75:3<451::aid-ijc20>3.0.co;2-a.
10
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.通过选定的Melan-A/MART-1免疫显性肽类似物在体外增强特定肿瘤反应性CTL的产生。
J Immunol. 1998 Feb 15;160(4):1750-8.

引用本文的文献

1
A full GMP process to select and amplify epitope-specific T lymphocytes for adoptive immunotherapy of metastatic melanoma.一种用于转移性黑色素瘤过继性免疫治疗的选择和扩增表位特异性T淋巴细胞的完整GMP流程。
Clin Dev Immunol. 2013;2013:932318. doi: 10.1155/2013/932318. Epub 2013 Sep 30.
2
Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients.黑色素瘤患者HLA-A2/黑色素瘤抗原A特异性T细胞克隆型中公共互补决定区3基序的鉴定及T细胞受体Vβ和Jβ链的偏向性利用
J Transl Med. 2009 Mar 24;7:21. doi: 10.1186/1479-5876-7-21.